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HIGHLIGHTS:  
 rs696884 impacts gene expression and physiology of prefrontal cortex. 
 rs696884 AA genotype is associated with lower RTN4R mRNA expression  
 rs696884 modulates dorsolateral prefrontal activity during working memory processing. 
 
 
2 
 
ABSTRACT 
The Nogo receptor (NgR) is implicated in neurodevelopmental processes and it participates 
in inhibiting axonal growth. Consistent with its high levels of expression in the prefrontal cortex, 
animal studies indicate that NgR is relevant for prefrontal-related cognitive processing. Given that 
genetic variation may alter mechanisms of gene expression impacting molecular and systems-level 
phenotypes, we investigated the association of genetic variation with the expression of the NgR 
coding gene (RTN4R), as well as with prefrontal correlates at progressively greater biological 
distance from gene effects. First, we studied the association of single nucleotide polymorphisms 
(SNPs) with RTN4R mRNA expression in postmortem prefrontal cortex of humans without 
psychiatric illnesses. Then, we probed in peripheral blood mononuclear cells (PBMCs) the 
association that we found in prefrontal tissue. Thus, we investigated whether functional genetic 
variation affecting RTN4R expression is also associated with prefrontal activity during working 
memory. We found that rs696884 (A/G) predicted these phenotypes. Specifically, the AA genotype 
was associated with lower RTN4R mRNA expression levels in the prefrontal cortex and PBMCs 
and inefficient prefrontal activity during working memory compared to the GG genotype. These 
results suggest that genetic variation associated with RTN4R mRNA expression influences 
prefrontal physiology in healthy individuals. Furthermore, they highlight the need for further 
investigations of the role of NgR in the pathophysiology of brain disorders associated with 
prefrontal dysfunction. 
 
KEYWORDS: rs696884, Nogo Receptor, mRNA expression; prefrontal activity, working memory 
 
1. INTRODUCTION 
Mechanisms regulating neuronal plasticity participate in the maturation of the brain and are 
critical determinants of brain function, including cognition (Hoistad et al., 2009). The Nogo 
receptor (NgR) complex has been implicated in the refinement of neuronal connectivity and it plays 
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a crucial role in limiting neuronal regeneration, sprouting, and plasticity (Akbik et al., 2012). Three 
myelin-associated growth inhibitory factors including Nogo-A, myelin associated glycoprotein 
(MAG), and oligodendrocyte myelin glycoprotein (OMgp), share NgR as a receptor. These factors 
regulate cytoskeletal dynamics and inhibit axonal growth (Atwal et al., 2008, Chen et al., 2000, 
Fournier et al., 2001, Lai et al., 1987, Wang et al., 2002). 
NgR is a glycosylphosphatidylinositol- (GPI-) anchored protein without a transmembrane 
domain (Barton et al., 2003, Fournier et al., 2001), it is highly expressed in the frontal cortex of 
animals and humans (Josephson et al., 2002; http://www.gtexportal.org), and it is localized to 
axonal membranes pre- and post-synaptically (Wang X. et al., 2002). Its signaling transduction 
requires membrane-associated co-receptors (Mi et al., 2004), allowing it to inhibit neurite 
outgrowth via the RhoA/ROCK/LIMK1/Rac1 pathway (Fournier et al., 2003, Hsieh et al., 2006, Mi 
et al., 2004, Niederost et al., 2002). Accordingly, genetic deletion or pharmacological inhibition of 
NgR enhance axonal plasticity after injury (Hanell et al., 2010, Lee et al., 2004, Mingorance et al., 
2004, Zheng et al., 2005). 
Other genetic evidence in animal models suggests that NgR signaling is also involved in 
cognitive processing, including those processes mediated by the prefrontal cortex (Budel et al., 
2008, Hsu et al., 2007, Karlen et al., 2009, Van Gaalen et al., 2012, Willi et al., 2010). For 
example, NgR knock-out mice have impaired spatial working memory and slower acquisition of 
spatial learning and memory (Budel et al., 2008, Van Gaalen et al., 2012). These findings are 
consistent with genetic evidence indicating that a hemizygous microdeletion occurring at the NgR 
gene locus (RTN4R - 22q11.2) is associated with prefrontal-related cognitive impairments in 
humans, including working memory, conflict monitoring, and visuo-spatial short-term memory 
deficits (Antshel et al., 2005, Bearden et al., 2001, Sobin et al., 2005, Woodin et al., 2001). 
 A series of studies also indicate that variations within RTN4R may have functional 
consequences for phenotypes at the molecular and behavioral level. In this regard, four RTN4R 
missense mutations have been associated with lower NogoA binding to NgR and lower inhibition of 
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NogoA-NgR mediated axonal growth (Budel et al., 2008). Another missense mutation predicted 
mild impairment of spatial memory performance in mice (Lazar et al., 2011). Moreover, the 
relevance of the variations in this gene to the development of brain disorders has been suggested by 
other studies that implicated several rare coding variants and single nucleotide polymorphisms 
(SNPs) in the RTN4R gene in the pathogenesis of schizophrenia (Budel et al., 2008, Hsu et al., 
2007, Liu et al., 2002, Sinibaldi et al., 2004). Consistently, previous evidence has suggested that the 
RTN4R genetic region (22q11) is relevant to this brain disorder (Pulver et al. 1994; Murphy et al. 
1999; Karayiorgou et al. 1995). 
The aim of this study was to investigate the association of RTN4R genetic variations with 
prefrontal molecular and imaging phenotypes in healthy humans. Given the widespread expression 
of NgR in the prefrontal cortex (Josephson et al., 2002), we focused on association of RTN4R 
variation with gene expression in this brain region. Furthermore, given the relevance of NgR for 
prefrontal-related cognitive processing (Karlsson et al., 2013, Lazar et al., 2011, Tong et al., 2013), 
we also investigated the association of functional RTN4R variation with prefrontal activity during 
working memory processing, which is tightly linked with this brain region. 
We used a hierarchical and stepwise translational genetic approach, which included both 
postmortem and in vivo experiments. In particular, we first identified RTN4R variation predicting 
RTN4R mRNA expression levels in postmortem human prefrontal cortex samples. Second, in order 
to extend these results to another tissue, we investigated the association between RTN4R variation 
and mRNA expression in peripheral blood mononuclear cells (PBMCs). Then, we also tested 
whether RTN4R functional genetic variation modulates prefrontal activity during working memory 
processing. We hypothesized that there was an association between RTN4R genetic variation and 
the molecular and imaging phenotypes that we investigated. 
 
2. MATERIAL AND METHODS 
2.1 Postmortem study 
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2.1.2 Association of RTN4R SNPs with prefrontal RTN4R mRNA expression levels 
Expression and genotype data from prefrontal tissues of 258 Caucasian (N = 112) and 
African American (N = 146) humans without psychiatric illness (90 females; mean [SD] age at 
death: 27.4 [22] years; RNA Integrity Number (RIN): 8.4 [0.9]; postmortem interval (PMI): 26.0 
[17.3] hours; PH: 6.5 [0.3]) were obtained using Braincloud, a publicly available database 
(www.braincloud.jhmi.edu) (Colantuoni et al., 2011). Subjects with evidence of macro- or 
microscopic neuropathology, drug or alcohol abuse, or psychiatric illness were excluded. RNA 
from prefrontal grey matter for each subject was analyzed using spotted oligonucleotide 
microarrays, yielding data from 30,176 gene expression probes. In the present study, we focused on 
RTN4R mRNA expression, which included two probes in this dataset (Clone Index 23242 and 
15361). In order to investigate the relationship between race and RTN4R expression, we performed 
an ANCOVA with RTN4R postmortem prefrontal expression as the dependent variable, race as the 
independent variable, and age at death, gender, RIN, PMI, and PH as nuisance covariates. Even if 
we found an effect of race on RTN4R mRNA expression levels, we still investigated both 
Caucasians and African Americans together to increase the sample size. 
DNA from cerebellar tissue was characterized in Braincloud with Illumina BeadChips, 
producing 625,439 SNP genotypes for each subject (Colantuoni et al., 2011). We examined 41 of 
these SNPs, which spanned 100 Kb upstream and downstream of RTN4R. Thus, separate 
ANCOVAs were performed to investigate the association of these SNPs with RTN4R expression as 
measured with each of the two probes, using age at death, PMI, PH, RIN, and gender as covariates 
of no interest. Results underwent Bonferroni corrections at p < 0.05 for the number of RTN4R SNPs 
investigated (N = 41) and the number of probes (N = 2). 
 Once we identified the SNP associated with RTN4R expression levels, we performed 
separate ANCOVAs in African Americans (N= 93 AA, 51 AG, 2 GG) and Caucasians (N= 25 AA, 
67 AG, 20 GG), given the association between expression of RTN4R and race (see results). Here, 
RTN4R gene expression was the dependent variable, the genotype of interest (rs696884, see results) 
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was the independent variable, and age, gender, RIN, PMI, and PH were the nuisance covariates. 
Since the GG group in African Americans included only two subjects, we collapsed AG and GG 
individuals together in a G carrier group (93 AA, 53 G carrier) while investigating genotype 
expression patterns in this race. 
 
 
2.2 In vivo study 
2.2.1 Subjects and genotyping 
The experimental protocol was approved by the local institutional review board and carried 
out in accordance with The Code of Ethics of the World Medical Association (Declaration of 
Helsinki). Participants gave written informed consent before being enrolled in the study. Overall, 
173 healthy Caucasian subjects from the region of Apulia, Italy participated in the study. Exclusion 
criteria were the presence of a neurological or psychiatric disorder, a first-degree relative affected 
by a psychiatric disease, brain trauma with loss of consciousness, alcohol or drug abuse, and an 
Intelligence Quotient (IQ) lower than 80 measured with the Wechsler Adult Intelligence Scale-
Revised (WAIS-R). All subjects underwent structured clinical interviews according to the DSM-IV 
(SCID-I non-patient’s edition) to exclude any psychiatric disorders. Furthermore, the experimental 
protocol included blood sampling for DNA extraction and a functional magnetic resonance imaging 
(fMRI)  session. 
DNA was extracted from the peripheral blood of all individuals using standard procedures 
(Kiagen Midi Kit). Genotyping was then performed using the Illumina Infinium HD Gemini 1M 
Duo BeadChips platform, which allowed the generation of genome-wide data. For the purpose of 
this study, we focused on the RTN4R variation (rs696884) selected with the postmortem 
investigation. ANOVA and χ2 tests were used to compare demographics (age, gender, socio-
economic status), handedness, and IQ as functions of rs696884. 
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2.3 Association of rs696884 with RTN4R expression in peripheral blood mononuclear cells 
(PBMCs) 
The association between RTN4R genetic variations (rs696884) and mRNA expression levels 
found in postmortem prefrontal tissues was also investigated in vivo in PBMCs from 41 healthy 
Caucasian individuals (AA = 14, AG = 16, GG = 11). Genotype groups were in Hardy-Weinberg 
Equilibrium (χ2 = 1.9; p = 0.16) and matched in terms of age and gender (all p > 0.2). The mRNA 
expressions levels were analyzed by quantitative real-time polymerase chain reaction (qPCR). In 
particular, peripheral blood was collected in Tempus™ Blood tubes (Life Technologies, Carlsbad, 
CA, USA), and all samples were frozen and stored at −20°C. RNA was extracted with the 
Tempus™ Spin RNA Isolation Kit (Life Technologies) and stored at −80°C. RNA concentrations 
and purity were evaluated with an Epoch spectrophotometer (Biotek, Winooski, VT, USA). 
Reverse-transcription (RT) of the total RNA into single-stranded cDNA was performed using the 
SuperScript VILO cDNA Synthesis Kit (Life Technologies). RTN4R expression was assessed using 
a TaqMan® probe (assay ID qHsaCEP0024213) from Bio-Rad (Hercules, CA, USA). The levels of 
RTN4R were normalized to actin B (ACTB) (4333762F, Life Technologies). Next, qPCR (20 μL 
reaction) was performed under standard conditions on an MJ Mini Opticon instrument (Bio-Rad) in 
triplicate. A negative control and a calibrator sample consisting of cDNA pooled from all samples 
were included for each assay. 
The relative expression of RTN4R was determined by performing the comparative method. 
First, data were normalized to ACTB and then to the calibrator. The results were expressed as 2-ΔΔCt, 
where ΔCt of each sample was defined as Ct (target gene = RTN4R) – Ct (reference gene = ACTB), 
and ΔΔCt = ΔCt sample - ΔCt calibrator. Finally, ANOVA was performed to evaluate the 
association between the genotypes and mRNA expression levels. 
 
2.4 Association of rs696884 with prefrontal activity during working memory processing 
2.4.1 Subjects and task 
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159 subjects underwent functional magnetic resonance imaging (fMRI) while performing 
the N-Back working memory task (Callicott et al., 1999). Rs696884 genotype groups (AA = 44, 
AG = 74, GG = 41) were matched with respect to age, socio-economic status, handedness, and IQ 
(all p > 0.05), but not for gender (χ2 = 6.5, p = 0.03). The genotype distribution was in Hardy-
Weinberg Equilibrium (χ2 = 0.75, p = 0.3). “N-back” referred to how far back in the sequence of 
stimuli the participant could recall. Stimuli consisted of numbers (from 1 to 4) shown randomly and 
displayed at the points of a diamond-shaped box. During the control condition (0-back) subjects 
were required to press on the button box the same stimuli displayed on the screen. During the 
memory condition (2-back), subjects had to recall the number shown for two stimuli before the one 
currently seen, while continuing to encode the stimuli as they appeared on the screen. Eight control 
and memory conditions of 30 seconds each alternated in a block design for a total of 4 minutes and 
8 seconds. Stimuli were presented via a back-projection system. Responses were recorded through a 
fiber optic button box allowing measurements of accuracy (percent correct responses) and reaction 
times (milliseconds). 
 
2.4.2 fMRI data acquisition and analysis 
The fMRI data were acquired on a General Electric 3 Tesla scanner using gradient-eco-
planar-imaging sequences (20 contiguous slices; TR/TE = 2000/30 ms; field of view: 24 cm; 
matrix: 64  64). Image analyses were performed using SPM8. Images were realigned, corrected for 
head motion, normalized into the MNI space, and smoothed with a 10 mm Gaussian filter. The data 
set included individuals with head movement < 2 mm of translation and < 1.5 mm of rotation. 
Residual movement was used as a regressor of no interest. Individual contrast images of 2-back 
versus 0-back were used in a random-effects model for group level analyses. An ANCOVA was 
performed with genotype as the independent variable and gender as the covariate of no interest. 
Results were constrained by a mask obtained by combining group activation maps for all 
participants. We used a statistical threshold of p < 0.05. This p-value was family-wise corrected 
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within our region of interest, which was the prefrontal cortex. More specifically, this correction was 
performed within BA 46 (as identified with the Wake Forest University PickAtlas - 
http://fmri.wfubmc.edu/cms/software#PickAtlas), which was the prefrontal region where the cluster 
of interest was located. We adopted this procedure to reduce the number of multiple comparisons. 
Blood-oxygen- level-dependent (BOLD) parameter estimates were extracted from the significant 
cluster using MarsBar and investigated with a post hoc Fisher’s test. Pearson’s test was used to 
determine the relationship between behavior and brain activity. ANCOVA with gender as a 
covariate of no interest was also performed on behavioral data acquired during scan acquisition. 
 
3. RESULTS 
3.1 Postmortem investigation 
3.1.2 Association between rs696884 and RTN4R mRNA expression levels in the postmortem 
prefrontal cortex 
ANCOVA indicated that Caucasian subjects had higher RTN4R expression levels than 
African Americans (F = 17.79, p = 0.00003). Separate ANCOVAs indicated an association between 
rs696884 (A/G) and RTN4R mRNA expression levels in the postmortem prefrontal cortex (F = 8.3; 
DF = 2; p = 0.02 after Bonferroni correction). Fisher’s post hoc analysis revealed that AA subjects 
had lower RTN4R mRNA expression levels relative to GG (p = 0.00003) and AG (p = 0.02) 
individuals. Furthermore, GG subjects had higher mRNA expression levels compared with AG 
individuals (p = 0.003) (Figure 1a). No other significant SNPs/mRNA expression associations were 
found. 
Post hoc ANCOVA in the subsample of Caucasian individuals indicated that there was a 
main effect of the rs696884 genotype on RTN4R expression (F = 3.07; DF = 2; p = 0.05). Fisher 
post hoc analysis revealed lower mRNA expression levels in AA and AG compared to GG 
individuals (p = 0.03). No differences were present between the AA and AG groups (p = 0.1). 
Finally, ANCOVA in African Americans did not indicate an effect of genotype on gene expression 
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(F = 1.3, p = 0.2). However, the average expression in AA subjects was lower than that in G carriers 
(A carrier = –0.30 and G carrier = –0.17), which was consistent with the association of the genotype 
in the overall group and in Caucasians. 
 
3.2 In vivo investigation 
3.2.1 Association of rs696884 with RTN4R mRNA expression levels in PBMCs 
 Consistent with the postmortem findings, ANOVA indicated that there was an effect of 
rs696884 on RTN4R mRNA expression levels in PBMCs of healthy Caucasian individuals (F = 5.7; 
DF = 2; p = 0.006). Fisher’s post hoc test revealed that AA individuals had lower mRNA expression 
levels compared to GG (p = 0.001) and AG subjects (p = 0.05). Meanwhile, no differences were 
found between AG and GG subjects (p = 0.1) (Figure 1b). 
 
3.2.2 Association between rs696884 and prefrontal activity during working memory 
There was no effect of genotype on behavioral data (accuracy p = 0.4; reaction time p = 0.8) 
in the fMRI samples. Thus, the genotype effect that we found on prefrontal activity reflected how 
the brain processed working memory, and not how individuals scored on the task. SPM8 ANCOVA 
revealed that there was an effect of the genotype on the left dorsolateral prefrontal cortex (BA46; x 
= –34 y = 34 z = 16; K = 54; Z = 3.4; FWE p = 0.05). Fisher’s post hoc test on BOLD values 
extracted from this significant cluster indicated that AA subjects had higher levels of activity 
compared to either AG (p = 0.001) or GG individuals (p = 0.001). No significant differences were 
present between the GG and AG genotype groups (p = 0.6) (Figure 2a–b). 
Pearson’s test indicated a negative correlation between parameter estimates extracted from 
the cluster associated with the main effect of the genotype and behavioral accuracy in AA 
individuals (r = –0.3, p = 0.01). This correlation was not present in AG (r = –0.1, p = 0.2) or GG (r 
= –0.09, p = 0.5) subjects (Figure 3a–c). 
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4. DISCUSSION 
The results of the present study indicate an association between RTN4R genetic variation 
and phenotypes linked to prefrontal function. In our hierarchical approach, we selected a SNP 
(rs696884) based on its association with RTN4R postmortem mRNA expression in the prefrontal 
cortex. Then, we extended this finding in PBMCs of healthy humans. Furthermore, we found that 
this SNP also modulated prefrontal activity during working memory processing. 
Rs696884 is an intergenic SNP located downstream of the RTN4R locus at position 
20183509 (GRCh37.p13). This polymorphism has not been investigated previously. We found that 
the AA genotype of this SNP was associated with lower RTN4R mRNA expression levels in the 
postmortem prefrontal cortex compared to the AG and GG genotypes. Additionally, we obtained 
similar results for the PBMCs of healthy subjects. Thus, our findings suggest that rs696884 may 
modulate the expression of RTN4R and possibly affect NgR function and signaling. 
In our study, rs696884 also influenced prefrontal function during working memory 
processing. In particular, we found that subjects with the AA genotype had greater dorsolateral 
prefrontal cortex activity during the 2-back condition compared to individuals with the G allele. 
This occurred despite the lack of genotype effects on behavioral performance. One interpretation of 
this finding is that AA individuals may need to recruit more neuronal resources to perform the task 
compared to AG and GG subjects, even though they displayed similar behavioral performance. In 
other words, greater prefrontal activity in our study may be an indicator of less efficient working 
memory processing in the prefrontal cortex of AA individuals, which has also been suggested by 
previous studies (Blasi et al., 2013, Callicott et al., 2003). Consistent with this interpretation, we 
found a negative correlation between behavioral accuracy and prefrontal activity during the 2-back 
condition in AA subjects. Thus, greater prefrontal engagement predicted lower behavioral 
proficiency in these individuals. Interestingly, this relationship was not observed for the other 
genotypic groups. This finding suggests that the functional role of the significant prefrontal cluster 
is less relevant for working memory processing in AG and GG individuals. 
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Rs696884 is an intergenic SNP located downstream of RTN4R. The molecular link between 
this polymorphism and expression of the RTN4R gene has yet to be elucidated. The UCSC genome 
browser (https://genome.ucsc.edu/) indicates that the DNA sequence that includes rs696884 is 
bound by the transcription factor CTCF. This is a zinc-finger protein involved in transcriptional 
regulation (Ohlsson et al., 2001) and it acts as an insulator that blocks enhancer activity (Bell et al., 
1999, Hou et al., 2008). A previous study indicated that constitutive CTCF loci seem to rely distant 
from transcription starting sites (Li et al., 2013) and one of the CTCF binding sites near the 
rs696884 locus has been identified (Li et al., 2013). Thus, it is possible that a mechanism by which 
rs696884 affects RTN4R expression relies on CTCF. However, further studies should address this 
topic. 
Some limitations of the study must be acknowledged. First, in the postmortem study, we 
found an association between race and RTN4R expression. On the other hand, the separate analysis 
of African Americans and Caucasians suggested that the two races have a consistent directionality 
in the relationship between rs696884 and RTN4R. The lower sample size may decrease power of 
detection of RTN4R effects. Thus, it is possible that population stratification might have biased the 
results. Another limitation is that the sample size for the PBMCs study was small. However, the 
consistency between the PBMC and postmortem findings may suggest that the association between 
genotype and mRNA expression in the peripheral blood is not driven by type I errors. An additional 
limitation involved the imaging study. Here, we reduced the number of multiple comparisons for 
statistical correction procedures using a sub-area within our region of interest (i.e., the prefrontal 
cortex). Indeed, this brain region is a very large area with multifaceted structural and functional 
characteristics. This may biologically justify our statistical approach. Furthermore, the consistencies 
between the molecular and fMRI results suggest that the findings that we report are not artefactual. 
Further studies with larger sample sizes might help to increase the power of detection of subtle 
genetic effects of RTN4R on complex phenotypes. 
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In conclusion, the hierarchical model used in this study indicates an association between a 
genetic variation affecting RTN4R expression and molecular and imaging phenotypes related to the 
prefrontal cortex. These findings suggest that a genetic predisposition for lower RTN4R mRNA 
expression levels may confer risks for sub-optimal patterns of prefrontal phenotypes relevant for 
complex brain disorders. 
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FIGURE CAPTIONS 
 
Figure 1.  
Association between rs696884 and RTN4R mRNA expression levels in postmortem prefrontal 
cortex and PBMc. a) Scatterplot of RTN4R expression in postmortem prefrontal cortex as a 
function of rs696884 in Caucasians and African Americans. b) Main effect of rs696884 on RTN4R 
mRNA expression levels in PBMC. AA individuals were associated with lower expression 
compared to AG and GG subjects. The mRNA expression was measured using the 2-ΔΔCt method. 
Error bars indicate a 95% confidence interval. See text for statistics. 
 
Figure 2.  
Association between rs696884 and prefrontal activity during working memory processing. a) 
Rendering of the brain showing the dorsolateral prefrontal functional cluster associated with a main 
effect of rs696884 during the 2-back working memory task (BA46, x = –34 y = 34 z = 16). b) 
Parameter estimates extracted from the cluster displayed in a). AA subjects had greater dorsolateral 
prefrontal activity compared to AG and GG individuals. Error bars indicate a 95% confidence 
interval. 
 
Figure 3. 
Correlation between rs696884 and accuracy during working memory. Negative correlation 
between BOLD signal extracted from the cluster associated with a main effect of rs696884 during 
working memory and accuracy (percent correct responses) during the 2-back task in AA (a), but not 
AG (b) or GG (c), individuals. Dashed lines indicate a 95% confidence interval. 
 
21 
 
 
 
 
 
22 
 
 
 
 
